TreeWAS – Variant ID: rs1399090

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K50.9 Crohn's disease, unspecified	0.021	0.979	0.000
E04.2 Non-toxic multinodular goitre	0.000	0.979	0.021
K50 Crohn's disease [regional enteritis]	0.021	0.979	0.000
K50.0 Crohn's disease of small intestine	0.020	0.980	0.000
K50.1 Crohn's disease of large intestine	0.019	0.981	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.983	0.017
E04 Other non-toxic goitre	0.000	0.983	0.017
K51 Ulcerative colitis	0.013	0.987	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.013	0.987	0.000
K50-K52 Noninfective enteritis and colitis	0.013	0.987	0.000
E04.8 Other specified non-toxic goitre	0.000	0.988	0.012
K50.8 Other Crohn's disease	0.012	0.988	0.000
K51.8 Other ulcerative colitis	0.012	0.988	0.000
N18.9 Chronic renal failure, unspecified	0.011	0.989	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.989	0.010
E04.0 Non-toxic diffuse goitre	0.000	0.989	0.010
S62.60 Fracture of other finger (closed)	0.000	0.990	0.010
K51.9 Ulcerative colitis, unspecified	0.010	0.990	0.000
K51.4 Pseudopolyposis of colon	0.010	0.990	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.010	0.990	0.000
K51.5 Mucosal proctocolitis	0.010	0.990	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.009	0.991	0.000
K51.2 Ulcerative (chronic) proctitis	0.009	0.991	0.000
C61 Malignant neoplasm of prostate	0.008	0.992	0.000
C91.1 Chronic lymphocytic leukaemia	0.007	0.993	0.000
N18 Chronic renal failure	0.006	0.994	0.000
C91 Lymphoid leukaemia	0.006	0.994	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.006	0.994	0.000
E53.8 Deficiency of other specified B group vitamins	0.006	0.994	0.000
S62.6 Fracture of other finger	0.000	0.994	0.006
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.006	0.994	0.000
N18.4 Chronic kidney disease, stage 4	0.006	0.994	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.994	0.006
E00-E07 Disorders of thyroid gland	0.000	0.994	0.006
E07 Other disorders of thyroid	0.000	0.994	0.006
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.006	0.994	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.994	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.005	0.994	0.000
N18.0 End-stage renal disease	0.005	0.995	0.000
C34.0 Main bronchus	0.000	0.995	0.005
C34 Malignant neoplasm of bronchus and lung	0.000	0.995	0.005
K52 Other non-infective gastro-enteritis and colitis	0.005	0.995	0.000
C34.9 Bronchus or lung, unspecified	0.000	0.995	0.005
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
C92 Myeloid leukaemia	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.6 Psychostimulants with abuse potential	0.005	0.995	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.005	0.995	0.000
N18.2 Chronic kidney disease, stage 2	0.005	0.995	0.000
S62.61 Fracture of other finger (open)	0.000	0.995	0.005
C34.1 Upper lobe, bronchus or lung	0.000	0.995	0.005
C92.0 Acute myeloid leukaemia	0.005	0.995	0.000
C91.4 Hairy-cell leukaemia	0.005	0.995	0.000
C83.3 Large cell (diffuse)	0.005	0.995	0.000
N18.8 Other chronic renal failure	0.005	0.995	0.000
N18.1 Chronic kidney disease, stage 1	0.005	0.995	0.000
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
M10.99 Gout, unspecified (Site unspecified)	0.005	0.995	0.000
C91.9 Lymphoid leukaemia, unspecified	0.005	0.995	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.005	0.995	0.000
C91.7 Other lymphoid leukaemia	0.005	0.995	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.005	0.995	0.000
C91.5 Adult T-cell leukaemia	0.005	0.995	0.000
C91.3 Prolymphocytic leukaemia	0.005	0.995	0.000
C91.2 Subacute lymphocytic leukaemia	0.005	0.995	0.000
C82.6 Cutaneous follicle centre lymphoma	0.005	0.995	0.000
C82.5 Diffuse follicle centre lymphoma	0.005	0.995	0.000
C82.4 Follicular lymphoma grade IIIb	0.005	0.995	0.000
C82.3 Follicular lymphoma grade IIIa	0.005	0.995	0.000
C82.2 Large cell, follicular	0.005	0.995	0.000
C82.0 Small cleaved cell, follicular	0.005	0.995	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.005	0.995	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.005	0.995	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.004	0.995	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.004	0.995	0.000
C83.0 Small cell (diffuse)	0.004	0.995	0.000
C88 Malignant immunoproliferative diseases	0.004	0.996	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.996	0.004
E00 Congenital iodine-deficiency syndrome	0.000	0.996	0.004
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.996	0.004
E07.8 Other specified disorders of thyroid	0.000	0.996	0.004
E07.1 Dyshormogenetic goitre	0.000	0.996	0.004
E07.0 Hypersecretion of calcitonin	0.000	0.996	0.004
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
C94 Other leukaemias of specified cell type	0.004	0.996	0.000
C93 Monocytic leukaemia	0.004	0.996	0.000
C86 Other specified types of T/NK-cell lymphoma	0.004	0.996	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.004	0.996	0.000
R79.8 Other specified abnormal findings of blood chemistry	0.004	0.996	0.000
C83.7 Burkitt's tumour	0.004	0.996	0.000
C83.6 Undifferentiated (diffuse)	0.004	0.996	0.000
C83.5 Lymphoblastic (diffuse)	0.004	0.996	0.000
C83.4 Immunoblastic (diffuse)	0.004	0.996	0.000
C83.2 Mixed small and large cell (diffuse)	0.004	0.996	0.000
C83.1 Small cleaved cell (diffuse)	0.004	0.996	0.000
C34.2 Middle lobe, bronchus or lung	0.000	0.996	0.004
C34.3 Lower lobe, bronchus or lung	0.000	0.996	0.004
C81 Hodgkin's disease	0.004	0.996	0.000
K52.3 Indeterminate colitis	0.004	0.996	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.996	0.004
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.004	0.996	0.000
E06 Thyroiditis	0.000	0.996	0.004
K52.0 Gastro-enteritis and colitis due to radiation	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.004	0.996	0.000
T42.4 Benzodiazepines	0.004	0.996	0.000
C92.9 Myeloid leukaemia, unspecified	0.004	0.996	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.004	0.996	0.000
C92.7 Other myeloid leukaemia	0.004	0.996	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.004	0.996	0.000
C92.5 Acute myelomonocytic leukaemia	0.004	0.996	0.000
C92.4 Acute promyelocytic leukaemia	0.004	0.996	0.000
C92.3 Myeloid sarcoma	0.004	0.996	0.000
C92.2 Subacute myeloid leukaemia	0.004	0.996	0.000
N18.5 Chronic kidney disease, stage 5	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
N73 Other female pelvic inflammatory diseases	0.004	0.996	0.000
N75 Diseases of Bartholin's gland	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
N72 Inflammatory disease of cervix uteri	0.004	0.996	0.000
N18.3 Chronic kidney disease, stage 3	0.004	0.996	0.000
T39.0 Salicylates	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
C92.1 Chronic myeloid leukaemia	0.003	0.996	0.000
N70-N77 Inflammatory diseases of female pelvic organs	0.004	0.996	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.996	0.003
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.996	0.003
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.996	0.003
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.996	0.003
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.996	0.003
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.996	0.003
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.996	0.003
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.996	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.996	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
N75.1 Abscess of Bartholin's gland	0.003	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
I63.9 Cerebral infarction, unspecified	0.000	0.997	0.003
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.003	0.997	0.000
C93.7 Other monocytic leukaemia	0.003	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.003	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.003	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.003	0.997	0.000
C93.0 Acute monocytic leukaemia	0.003	0.997	0.000
C94.7 Other specified leukaemias	0.003	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.003	0.997	0.000
C94.5 Acute myelofibrosis	0.003	0.997	0.000
C94.4 Acute panmyelosis	0.003	0.997	0.000
C94.3 Mast cell leukaemia	0.003	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.003	0.997	0.000
C94.1 Chronic erythraemia	0.003	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.003	0.997	0.000
C95.9 Leukaemia, unspecified	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
C96.8 Histiocytic sarcoma	0.003	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.003	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.003	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.003	0.997	0.000
C96.3 True histiocytic lymphoma	0.003	0.997	0.000
C96.2 Malignant mast cell tumour	0.003	0.997	0.000
C96.1 Malignant histiocytosis	0.003	0.997	0.000
C96.0 Letterer-Siwe disease	0.003	0.997	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.003	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.003	0.997	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.003	0.997	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.003	0.997	0.000
C84.5 Other and unspecified T-cell lymphomas	0.003	0.997	0.000
C84.3 Lymphoepithelioid lymphoma	0.003	0.997	0.000
C84.2 T-zone lymphoma	0.003	0.997	0.000
C84.1 Sezary's diease	0.003	0.997	0.000
C84.0 Mycosis fungoides	0.003	0.997	0.000
N75.0 Cyst of Bartholin's gland	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
N73.6 Female pelvic peritoneal adhesions	0.003	0.997	0.000
E53 Deficiency of other B group vitamins	0.003	0.997	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.997	0.003
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
C81.1 Nodular sclerosis	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
E06.9 Thyroiditis, unspecified	0.000	0.997	0.003
E06.5 Other chronic thyroiditis	0.000	0.997	0.003
E06.4 Drug-induced thyroiditis	0.000	0.997	0.003
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.997	0.003
E06.1 Subacute thyroiditis	0.000	0.997	0.003
E06.0 Acute thyroiditis	0.000	0.997	0.003
Z51.3 Blood transfusion without reported diagnosis	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
N70 Salpingitis and oophoritis	0.003	0.997	0.000
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
T42.1 Iminostilbenes	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
C60-C63 Malignant neoplasms of male genital organs	0.003	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
L30.9 Dermatitis, unspecified	0.003	0.997	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.003	0.997	0.000
N73.5 Female pelvic peritonitis, unspecified	0.003	0.997	0.000
N73.4 Female chronic pelvic peritonitis	0.003	0.997	0.000
N73.3 Female acute pelvic peritonitis	0.003	0.997	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.003	0.997	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.003	0.997	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.003	0.997	0.000
N76 Other inflammation of vagina and vulva	0.003	0.997	0.000
E03 Other hypothyroidism	0.000	0.997	0.003
C81.9 Hodgkin's disease, unspecified	0.003	0.997	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
N76.8 Other specified inflammation of vagina and vulva	0.003	0.997	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.003	0.997	0.000
N75.8 Other diseases of Bartholin's gland	0.003	0.997	0.000
I63 Cerebral infarction	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
K52.1 Toxic gastro-enteritis and colitis	0.003	0.997	0.000
I27.0 Primary pulmonary hypertension	0.000	0.997	0.003
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.997	0.003
N70.1 Chronic salpingitis and oophoritis	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
Z13.9 Special screening examination, unspecified	0.000	0.997	0.003
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y60.0 During surgical operation	0.000	0.997	0.003
N76.3 Subacute and chronic vulvitis	0.003	0.997	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.000	0.997	0.003
S92.30 Fracture of metatarsal bone (closed)	0.003	0.997	0.000
E06.3 Autoimmune thyroiditis	0.000	0.997	0.002
N76.6 Ulceration of vulva	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
E53.9 Vitamin B deficiency, unspecified	0.002	0.997	0.000
E53.1 Pyridoxine deficiency	0.002	0.997	0.000
E53.0 Riboflavin deficiency	0.002	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.997	0.000
E05.8 Other thyrotoxicosis	0.000	0.997	0.002
E05.5 Thyroid crisis or storm	0.000	0.997	0.002
E05.4 Thyrotoxicosis factitia	0.000	0.997	0.002
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.997	0.002
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.997	0.002
E03.8 Other specified hypothyroidism	0.000	0.997	0.002
R79 Other abnormal findings of blood chemistry	0.003	0.997	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.002	0.997	0.000
N70.0 Acute salpingitis and oophoritis	0.002	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.997	0.000
T45.5 Anticoagulants	0.002	0.997	0.000
T45.4 Iron and its compounds	0.002	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
T46.7 Peripheral vasodilators	0.002	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
T46.1 Calcium-channel blockers	0.002	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.997	0.002
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.000	0.998	0.002
R79.0 Abnormal level of blood mineral	0.002	0.998	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.002	0.998	0.000
C60 Malignant neoplasm of penis	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
E03.5 Myxoedema coma	0.000	0.998	0.002
E03.4 Atrophy of thyroid (acquired)	0.000	0.998	0.002
E03.3 Postinfectious hypothyroidism	0.000	0.998	0.002
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.998	0.002
E03.1 Congenital hypothyroidism without goitre	0.000	0.998	0.002
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.998	0.002
N76.5 Ulceration of vagina	0.002	0.998	0.000
N76.1 Subacute and chronic vaginitis	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
H91.9 Hearing loss, unspecified	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.000	0.998	0.002
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.000	0.998	0.002
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
I63.8 Other cerebral infarction	0.000	0.998	0.002
M10.9 Gout, unspecified	0.002	0.998	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.998	0.002
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.002	0.998	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.002	0.998	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.002	0.998	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.002	0.998	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.002	0.998	0.000
N74.0 Tuberculous infection of cervix uteri	0.002	0.998	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.002	0.998	0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
N76.2 Acute vulvitis	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.000	0.998	0.002
H18.9 Disorder of cornea, unspecified	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
C62 Malignant neoplasm of testis	0.002	0.998	0.000
N71 Inflammatory disease of uterus, except cervix	0.002	0.998	0.000
N76.4 Abscess of vulva	0.002	0.998	0.000
L30 Other dermatitis	0.002	0.998	0.000
H18.1 Bullous keratopathy	0.002	0.998	0.000
I44.0 Atrioventricular block, first degree	0.000	0.998	0.002
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.998	0.002
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.998	0.002
C31 Malignant neoplasm of accessory sinuses	0.000	0.998	0.002
C37 Malignant neoplasm of thymus	0.000	0.998	0.002
C33 Malignant neoplasm of trachea	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
C60.9 Penis, unspecified	0.002	0.998	0.000
C60.8 Overlapping lesion of penis	0.002	0.998	0.000
C60.2 Body of penis	0.002	0.998	0.000
C60.1 Glans penis	0.002	0.998	0.000
C60.0 Prepuce	0.002	0.998	0.000
C63.9 Male genital organ, unspecified	0.002	0.998	0.000
C63.8 Overlapping lesion of male genital organs	0.002	0.998	0.000
C63.7 Other specified male genital organs	0.002	0.998	0.000
C63.2 Scrotum	0.002	0.998	0.000
C63.1 Spermatic cord	0.002	0.998	0.000
C63.0 Epididymis	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
C32.9 Larynx, unspecified	0.000	0.998	0.002
S62 Fracture at wrist and hand level	0.000	0.998	0.002
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
H18 Other disorders of cornea	0.002	0.998	0.000
C90.0 Multiple myeloma	0.002	0.998	0.000
K81.1 Chronic cholecystitis	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
C01 Malignant neoplasm of base of tongue	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
I77.1 Stricture of artery	0.000	0.998	0.002
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.998	0.002
M10.98 Gout, unspecified (Other)	0.002	0.998	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M10.94 Gout, unspecified (Hand)	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
M10.92 Gout, unspecified (Upper arm)	0.002	0.998	0.000
M10.91 Gout, unspecified (Shoulder region)	0.002	0.998	0.000
M25.59 Pain in joint (Site unspecified)	0.002	0.998	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.000	0.998	0.002
C32.3 Laryngeal cartilage	0.000	0.998	0.002
C32.2 Subglottis	0.000	0.998	0.002
C32.1 Supraglottis	0.000	0.998	0.002
C32.0 Glottis	0.000	0.998	0.002
M10.96 Gout, unspecified (Lower leg)	0.002	0.998	0.000
H18.4 Corneal degeneration	0.002	0.998	0.000
R94.4 Abnormal results of kidney function studies	0.002	0.998	0.000
C62.1 Descended testis	0.002	0.998	0.000
C62.0 Undescended testis	0.002	0.998	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.998	0.002
C10.9 Oropharynx, unspecified	0.002	0.998	0.000
N71.0 Acute inflammatory disease of uterus	0.002	0.998	0.000
C04.9 Floor of mouth, unspecified	0.002	0.998	0.000
H18.8 Other specified disorders of cornea	0.002	0.998	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
L30.5 Pityriasis alba	0.002	0.998	0.000
L30.4 Erythema intertrigo	0.002	0.998	0.000
L30.3 Infective dermatitis	0.002	0.998	0.000
L30.2 Cutaneous autosensitisation	0.002	0.998	0.000
L30.1 Dyshidrosis [pompholyx]	0.002	0.998	0.000
L30.0 Nummular dermatitis	0.002	0.998	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.002	0.998	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.998	0.002
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.998	0.002
C10 Malignant neoplasm of oropharynx	0.002	0.998	0.000
C04 Malignant neoplasm of floor of mouth	0.002	0.998	0.000
C09.9 Tonsil, unspecified	0.002	0.998	0.000
C09 Malignant neoplasm of tonsil	0.002	0.998	0.000
C31.9 Accessory sinus, unspecified	0.000	0.998	0.002
C31.8 Overlapping lesion of accessory sinuses	0.000	0.998	0.002
C31.3 Sphenoidal sinus	0.000	0.998	0.002
C31.2 Frontal sinus	0.000	0.998	0.002
C31.1 Ethmoidal sinus	0.000	0.998	0.002
C31.0 Maxillary sinus	0.000	0.998	0.002
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.998	0.002
C38.4 Pleura	0.000	0.998	0.002
C38.3 Mediastinum, part unspecified	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations